Abstract. Background. Objective
|
|
- Marybeth McCormick
- 6 years ago
- Views:
Transcription
1 Molecular epidemiology of clinical tissues with multi-parameter IHC Poster 237 J Ruan 1, T Hope 1, J Rheinhardt 2, D Wang 2, R Levenson 1, T Nielsen 3, H Gardner 2, C Hoyt 1 1 CRi, Woburn, Massachusetts, USA, 2 Oncology Translational Laboratories, Novartis Institutes for Biomedical Research,Cambridge, Massachusetts, USA, 3 British Columbia Cancer Agency, Vancouver B.C Seeing life in a new light.
2 Abstract Background A common goal in pharmaceutical research is to discover correlations between clinical outcomes and complex protein expression and interaction patterns in tissue sections. Correlations inform target validation, trial design, patient selection, response assessment, and, if trials are successful, the diagnostic component of theranostics. However, to successfully detect multiple, often weakly-expressed targets in clinical tissue sections requires appropriate staining protocols, advanced instrumentation and powerful software. Objective After developing multi-label immunohistochemical staining methods that were quantitative, independent, and specific, the goal was to create and validate an automated, whole-slide scanning imaging system that could be used to capture and distinguish multiple labels. Image analysis algorithms were used to differentiate relevant tissue regions (e.g., malignant and normal epithelia, stroma, necrosis, etc.) and segment cellular compartments (nuclei, cytoplasm, and membrane) to allow for detailed, spatially resolved multiparameter quantitation. Such as system would have an immediate application to signal-transduction research applied to conventional tissue sections. Here we describe this platform, and present results obtained from analysis of breast cancer tissue microarrays (TMAs). A key technological component of this project was multispectral imaging, which enabled the multiplexed detection. Methods and Materials Multispectral imaging, using a spectrally enabled whole-slide scanning system, was performed on two sets of a 712-core TMA (356 patients represented in duplicate). The first set was stained for ER, PR, and Her2, with a counterstain of hematoxylin, and the second stained for PR, Her1, and Her2, with a counterstain of hematoxylin. Single-stain data for comparison was obtained from previously stained and analyzed TMAs. IHC signals were spectrally unmixed and isolated from each other and the hematoxylin counterstain. Machine-learning-based automated image analysis was performed to locate cancer cells, segment subcellular compartments, and extract IHC signals on a per-cell basis. Relative stain intensities on a per-cell basis were analyzed with flowcytometry analysis software. Results and Discussion Multispectral 20x images obtained of each TMA core were acquired and spectrally unmixed at a rate of three cores per minute. Automated image analysis, using algorithms that could be developed by end-users in under 2 hours, took approximately 10 seconds per core, segmenting cancer-containing regions and extracting signals from relevant cell compartments. Concordance (r) between visual scores of single stain sections and the semi-automated scores of triple-stained samples indicate equivalency (r values ranging from 0.65 to 0.85), thus validating that multiplexed IHC faithfully reflects data obtainable with single-stains. Thus, multiplexed staining and detection, coupled with flow-cytometry analysis tools can be used to explore multiple protein expression patterns on a cell-by-cell basis, something that cannot be accomplished with serial single stains. Together, the innovative multispectral platform and software can capture cellular and subcellular expression details in an intact tissue architectural context.
3 An approach to utilizing multiplexed IHC in targeted drug development Explore pathway patterns with TMAs Correlate patterns with outcomes Field #5 Develop multiplexed IHC protocols % 1.69% dab % 43.74% vector red Offer theranostic medical products Perform efficacy studies D x + R x
4 Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 1 : Scan TMA, Find Cores, Extract High-Power Fields (20x) RGB Image (20x) of a core
5 Multi-Parameter IHC Demonstration with ER, PR, and Her2 2 Step : Spectrally unmix stains from each other Spectral Library hematoxylin DAB (ER) Vector Red (Her2)
6 Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 3 : Classify tissue with machine learning algorithms (red = tumor, green = stroma, blue = background). Segment cellular compartments, extract spectrally unmixed signals from associated compartments, and export per-cell protein expression. Core (12,6) Core (7,7) Core (12,6) Core (7,7) Core (2,11) Core (10,3) Core (2,11) Core (10,3) Multi-parameter flow-cytometry-like outputs, but retaining tissue architecture and heterogeneity Machine learning-based automated image analysis has simple learn-by-example interface and is fast (10 20 seconds per image)
7 Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 4 : correlate clusters with clinical outcomes. Per-cell multi-parameter IHC Core (2,11) Core (10,3) Core (12,6) Core (7,7) Her Her ER 4000 Per-cell multi-parameter IHC Her PR Per-cell multi-parameter IHC 3-D scatter plots show multi-parameter data extracted from individual cells. Note distinct clusters. Data points in the plots represent cells, and can be assessed by cluster analysis or quadrant analysis, commonly use in flow cytometry for phenotyping (double negative, single positive, double positive, etc.) ER PR 0% 0% 11% 75% 1% 0% 16% 69% 2% 98% 1% 13% 99% 0% 3% 12% 98% 0% 0% 0% 2% 84% 0% 0% 2% 0% 8% 92% 0% 14% 0% 100%
8 Concordance between automated and visual scores Automated, quantitative measurements performed on spectrally unmixed stain signals were compared with visual 0-3+ and % positivity scores performed by pathologists at BCCA on single-stained serial sections of the same tissue micro-array. R-values of.80 to.90, were typical, showing equivalency ER % positivity R=0.80 Her scores Visual Scores Automated Scores R=0.85
9 Spectral Imaging Acquisition Images at different wavelengths Assemble the images into a data cube Spectrum at every (x,y) pixel Spectrum from nucleus with both hematoxylin and DAB Spectra of pure chromogens collected from single- stained sections Nuance TM Multispectral Imaging Systems Spectrum from membrane with just red stain Spectrum from stroma with just hematoxylin Unmixed DAB Component Unmixed Red Component RGB Representation of Spectral Cube Unmixed Hematoxylin Component Once unmixed, stains can be measured accurately.
10 Conclusions Multispectral imaging coupled with multiplexed IHC labeling is a practical and effective approach to detecting, isolating and quantitating low-expressing signaling pathway proteins in clinical samples CRi automated image analysis and spectral imaging enables practical multi-parameter molecular assessments of cells in intact tissue sections, thus enabling flow-on-a-slide with the added benefit of capturing critical phenotype heterogeneity across tissue sections.
Next-Gen Analytics in Digital Pathology
Next-Gen Analytics in Digital Pathology Cliff Hoyt, CTO Cambridge Research & Instrumentation April 29, 2010 Seeing life in a new light 1 Digital Pathology Today Acquisition, storage, dissemination, remote
More informationImmune Cell Phenotyping in Solid Tumors using Quantitative Pathology
Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology James R. Mansfield Director of Quantitative Pathology Applications 2009 PerkinElmer What is Quantitative Pathology? Quantitative Pathology
More informationDeciphering the biology that drives response to immunotherapy
Deciphering the biology that drives response to immunotherapy Phenoptics TM Quantitative Pathology Platform Trent Norris, Field Application Scientist September 15, 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH
More informationGaining New Insights Through IF Multiplexed Staining and Analysis. Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory October 5, 2017
Gaining New Insights Through IF Multiplexed Staining and Analysis Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory Assessing more from Tissue Sections Gaps with More Common Methods Most common
More informationImage analysis in IHC overview, considerations and applications
Image analysis in IHC overview, considerations and applications Rasmus Røge, MD, Institute of Pathology, Aalborg University Hospital NordiQC workshop September 2016 Aalborg, Denmark Outline Theory Image
More informationNext-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry
Nat Met, April 2014 Nat Med, April 2014 Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry Journal Club Timo Böge Overview Introduction Conventional Immunohistochemistry
More informationVisual interpretation in pathology
13 Visual interpretation in pathology Tissue architecture (alteration) evaluation e.g., for grading prostate cancer Immunohistochemistry (IHC) staining scoring e.g., HER2 in breast cancer (companion diagnostic
More informationCentral Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham
Central Pathology Review and Tissue MicroArrays Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham What is a tissue microarray? Tissue microarrays (TMAs) consist of paraffin blocks in which
More informationFinal Project Report Sean Fischer CS229 Introduction
Introduction The field of pathology is concerned with identifying and understanding the biological causes and effects of disease through the study of morphological, cellular, and molecular features in
More informationSpatially resolved multiparametric single cell analysis. Technical Journal Club 19th September 2017 Christina Müller (Group Speck)
Spatially resolved multiparametric single cell analysis Technical Journal Club 19th September 2017 Christina Müller (Group Speck) Why spatially resolved multiparametric single cell analysis? Multiparametric
More informationHIGH CONTENT ANALYSIS WITH CELLULAR AND TISSUE SYSTEMS BIOLOGY: A BRIDGE BETWEEN CANCER CELL BIOLOGY AND TISSUE-BASED DIAGNOSTICS
Chapter for "The Molecular Basis of Cancer", 4th Edition (In Press) HIGH CONTENT ANALYSIS WITH CELLULAR AND TISSUE SYSTEMS BIOLOGY: A BRIDGE BETWEEN CANCER CELL BIOLOGY AND TISSUE-BASED DIAGNOSTICS Albert
More informationDigital Pathology and CAP Guidelines
Digital Pathology and CAP Guidelines Frequently asked questions The VENTANA family of digital pathology products empowers you with the convenience of a comprehensive image and workflow solution. When used
More informationDoes digital IHC need digital tissue controls?
VILNIUS UNIVERSITY Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system Arvydas Laurinavicius
More informationLayered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue
Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to
More informationThe following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details.
Disclaimer: The following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details. These slides are proprietary and should not
More informationWorkflow. Connecting the Pieces For Total Patient Care
Workflow Connecting the Pieces For Total Patient Care Biocare provides a full line of IHC and molecular pathology products for cancer and infectious disease diagnosis. From a full range of equipment: including
More informationOOSIGHT IVF. See what you ve been missing.
OOSIGHT IVF IMAGING SYSTEM See what you ve been missing. Oosight. The non-invasive imaging system that reveals critical structures in the oocyte to enable better grading. Adding Oosight to your lab can
More informationHER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer
P A T H O L O G Y HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer FROM CERTAINTY COMES TRUST For in vitro diagnostic use HER2 CISH pharmdx Kit HER2 CISH pharmdx Kit is intended for dual-color
More informationGeisinger Clinic Annual Progress Report: 2011 Nonformula Grant
Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant Reporting Period July 1, 2012 June 30, 2013 Nonformula Grant Overview The Geisinger Clinic received $1,000,000 in nonformula funds for the
More informationSurgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.
Surgical Pathology Lab of the Future Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc. 28 April 2010 Objective Demonstrate how the next generation
More informationIncorporating pharmacodynamic, response and patient selection biomarkers. Paul Elvin PhD Chief Translational Science Officer Aptus Clinical
Incorporating pharmacodynamic, response and patient selection biomarkers Paul Elvin PhD Chief Translational Science Officer Aptus Clinical 22 Oncology drug development Biomarkers key for: Strong hypothesis
More informationSupplementary Online Content
Supplementary Online Content Bell EH, Pugh SL, McElroy JP, et al. Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG Oncology
More informationCOMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME
COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME Maria Lunardi MD Anatomic Pathology Fracastoro Hospital San Bonifacio, Verona -Italy HER2-neu
More informationLOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN Mirette Hanna MD Clinical pathology PhD (candidate) Experimental medicine MSc Clinical and chemical
More informationPOC Brain Tumor Segmentation. vlife Use Case
Brain Tumor Segmentation vlife Use Case 1 Automatic Brain Tumor Segmentation using CNN Background Brain tumor segmentation seeks to separate healthy tissue from tumorous regions such as the advancing tumor,
More informationInterpreting Therapeutic Response on Immune Cell Number and Spatial Distribution within the Tumor Microenvironment. Lorcan Sherry, CSO OracleBio
Interpreting Therapeutic Response on Immune Cell Number and Spatial Distribution within the Tumor Microenvironment Lorcan Sherry, CSO OracleBio Company Overview OracleBio is a specialised CRO providing
More informationmanifestations of disease (mostly clinical medicine)
Histopathology : microscopic examination of tissue in order to study the manifestations of disease (mostly clinical medicine) https://medium.com/the-physics-arxiv-blog/ghost-imaging-reassembles-images-scattered-by-breast-tissue
More informationProteomic Biomarker Discovery in Breast Cancer
Proteomic Biomarker Discovery in Breast Cancer Rob Baxter Laboratory for Cellular and Diagnostic Proteomics Kolling Institute, University of Sydney, Royal North Shore Hospital robert.baxter@sydney.edu.au
More informationIDH1 R132H/ATRX Immunohistochemical validation
IDH1 R132H/ATRX Immunohistochemical validation CIQC/DSM 2016 12 June 2016 0835-0905 Stephen Yip, M.D., Ph.D., FRCPC University of British Columbia Disclosure Statement I have nothing to disclose I will
More informationSingle and Multiplex Immunohistochemistry
Single and Multiplex Immunohistochemistry Steve Westra, BS Reagent Product Specialist Leica Biosystems IHC Theory Polyclonal vs Monoclonal Polyclonal reagents Detect a multitude of epitopes Batch to batch
More informationOptimal algorithm for HER2 testing
Optimal algorithm for HER2 testing The revised definition of IHC 2+ (equivocal) is invasive breast cancer with Weak to moderate complete membrane staining observed in >10% of tumor cells. (see Figure 1
More informationLC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS
LC/MS/MS SOLUTIONS FOR LIPIDOMICS Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS Lipids play a key role in many biological processes, such as the formation of cell membranes and signaling
More informationClinical evaluation of melanomas and common nevi by spectral imaging
Clinical evaluation of melanomas and common nevi by spectral imaging Ilze Diebele, 1,* Ilona Kuzmina, 1 Alexey Lihachev, 1 Janis Kapostinsh, 2 Alexander Derjabo, 2 Lauma Valeine, 3 and Janis Spigulis 1
More informationTranslating Tissue Phenomics and Big Data Distillation to Clinical Histopathology
International Symposium for Tissue Phenomics 2016 Translating Tissue Phenomics and Big Data Distillation to Clinical Histopathology Dr Peter Caie Senior Research Fellow QUAntitative and Digital (QUAD)
More informationIdentification of Sickle Cells using Digital Image Processing. Academic Year Annexure I
Academic Year 2014-15 Annexure I 1. Project Title: Identification of Sickle Cells using Digital Image Processing TABLE OF CONTENTS 1.1 Abstract 1-1 1.2 Motivation 1-1 1.3 Objective 2-2 2.1 Block Diagram
More informationBiomarker strategy for Personalized Healthcare at Roche
Biomarker strategy for Personalized Healthcare at Roche E mi l i a An d e r sso n o n b e h a l f o f t h e I R I S t e a m No v 2 0 1 6 6th Munich Biomarker Conference Nov 29th 30th, 2016 Ramada Hotel
More informationDeep learning approaches to medical applications
Deep learning approaches to medical applications Joseph Paul Cohen Postdoctoral Fellow at Montreal Institute for Learning Algorithms Friend of the Farlow Fellow at Harvard University U.S. National Science
More informationWelcome! HER2 TESTING DIAGNOSTIC ACCURACY 4/11/2016
HER2 TESTING DIAGNOSTIC ACCURACY Can t We Finally Get It Right? Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Seattle, Washington Clinical Professor of Pathology University
More informationAssessment performed on Friday, September 18, 2015, at Vancouver General Hospital
Assessors report for ciqc Run 49: ATRX (June 2015) Assessors: S Yip and J Won (recorder) Assessment performed on Friday, September 18, 2015, at Vancouver General Hospital Background The combined application
More informationA New Approach For an Improved Multiple Brain Lesion Segmentation
A New Approach For an Improved Multiple Brain Lesion Segmentation Prof. Shanthi Mahesh 1, Karthik Bharadwaj N 2, Suhas A Bhyratae 3, Karthik Raju V 4, Karthik M N 5 Department of ISE, Atria Institute of
More informationPractical Applications of Digital Pathology
Digital pathology will continue to advance and provide precise prognostic information and help guide treatment decisions. Life in Stone. Photograph courtesy of Craig Damlo. www.soapboxrocket.com. Practical
More informationIs digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK
Is digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK Pathologists and microscopes. 1850 Rudolph Virchow (1821-1902),
More informationCo-PI: Amy Trentham-Dietz, PhD
AD Award Number: W81XWH-11-1-0228 TITLE: Tumor Microenvironment and Progression to Invasion after a Diagnosis of Ductal Carcinoma In situ PRINCIPAL INVESTIGATOR: Patricia J. Keely, PhD Co-PI: Amy Trentham-Dietz,
More informationAUTOMATIC BRAIN TUMOR DETECTION AND CLASSIFICATION USING SVM CLASSIFIER
AUTOMATIC BRAIN TUMOR DETECTION AND CLASSIFICATION USING SVM CLASSIFIER 1 SONU SUHAG, 2 LALIT MOHAN SAINI 1,2 School of Biomedical Engineering, National Institute of Technology, Kurukshetra, Haryana -
More informationAssigning B cell Maturity in Pediatric Leukemia Gabi Fragiadakis 1, Jamie Irvine 2 1 Microbiology and Immunology, 2 Computer Science
Assigning B cell Maturity in Pediatric Leukemia Gabi Fragiadakis 1, Jamie Irvine 2 1 Microbiology and Immunology, 2 Computer Science Abstract One method for analyzing pediatric B cell leukemia is to categorize
More informationCaPTk: Cancer Imaging Phenomics Toolkit
CaPTk: Cancer Imaging Phenomics Toolkit Interaction Personalized Diagnostics CaPTk Quantitative Imaging Phenomic Features Radiogenomics Image Analysis Machine Learning What is CaPTk? A dynamically growing
More informationDharmesh A Sarvaiya 1, Prof. Mehul Barot 2
Detection of Lung Cancer using Sputum Image Segmentation. Dharmesh A Sarvaiya 1, Prof. Mehul Barot 2 1,2 Department of Computer Engineering, L.D.R.P Institute of Technology & Research, KSV University,
More informationStatistical Analysis of Hematoxylin and Eosin Stained Nuclei from Breast Cancer Tissue
Statistical Analysis of Hematoxylin and Eosin Stained Nuclei from Breast Cancer Tissue Manuel E. Ruidíaz, Marta Sartor, Sarah L. Blair, Jessica Wang-Rodriguez, Davorka Messmer, Brad Messmer, William C.
More informationInti Zlobec 1*, Viktor H Koelzer 1,2, Heather Dawson 1,2, Aurel Perren 1,2 and Alessandro Lugli 1,2
Zlobec et al. Journal of Translational Medicine 2013, 11:104 RESEARCH Open Access Next-generation tissue microarray (ngtma) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO
More informationAutomatic Diagnosis of Ovarian Carcinomas via Sparse Multiresolution Tissue Representation
Automatic Diagnosis of Ovarian Carcinomas via Sparse Multiresolution Tissue Representation Aïcha BenTaieb, Hector Li-Chang, David Huntsman, Ghassan Hamarneh Medical Image Analysis Lab, Simon Fraser University,
More informationARTIFICIAL INTELLIGENCE FOR DIGITAL PATHOLOGY. Kyunghyun Paeng, Co-founder and Research Scientist, Lunit Inc.
ARTIFICIAL INTELLIGENCE FOR DIGITAL PATHOLOGY Kyunghyun Paeng, Co-founder and Research Scientist, Lunit Inc. 1. BACKGROUND: DIGITAL PATHOLOGY 2. APPLICATIONS AGENDA BREAST CANCER PROSTATE CANCER 3. DEMONSTRATIONS
More informationChemical profiling for theranostics applications
Chemical profiling for theranostics applications LBRC researchers: Ramachandra Dasari, Jeon Woong Kang, Surya Singh External Collaborators: Prof. Venu Raman Technology Overview: Non-targeted chemical profiling
More informationProduct Introduction
Product Introduction Product Codes: HCL026, HCL027 and HCL028 Contents Introduction to HER2 2 HER2 immunohistochemistry 3 Cell lines as controls 5 HER2 Analyte Control DR IHC 7 HER2 Analyte Control DR
More informationLN04 - Lymphoma Tissue Microarray
Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA LN04 - Lymphoma Tissue Microarray
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More informationCancer Cells Detection using OTSU Threshold Algorithm
Cancer Cells Detection using OTSU Threshold Algorithm Nalluri Sunny 1 Velagapudi Ramakrishna Siddhartha Engineering College Mithinti Srikanth 2 Velagapudi Ramakrishna Siddhartha Engineering College Kodali
More informationHER2 FISH pharmdx TM Interpretation Guide - Breast Cancer
P A T H O L O G Y HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer For In Vitro Diagnostic Use FDA approved as an aid in the assessment of patients for whom Herceptin TM (trastuzumab) treatment
More informationUsing CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification
Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification Kenna Mawk, D.V.M. Informatics Product Manager Ciphergen Biosystems, Inc. Outline Introduction to ProteinChip Technology
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationApplication Note # MT-111 Concise Interpretation of MALDI Imaging Data by Probabilistic Latent Semantic Analysis (plsa)
Application Note # MT-111 Concise Interpretation of MALDI Imaging Data by Probabilistic Latent Semantic Analysis (plsa) MALDI imaging datasets can be very information-rich, containing hundreds of mass
More informationSpectral Analysis of Normal and Malignant Microarray Tissue Sections Using a Novel Micro-optoelectricalmechanical System Background: Design:
Spectral Analysis of Normal and Malignant Microarray Tissue Sections Using a Novel Micro-optoelectricalmechanical System (Mod Pathol 24; 17 Suppl 1: 358A). M Maggioni 1,3, G L Davis 2,3,, F J Warner 1,3,4,
More informationEARLY STAGE DIAGNOSIS OF LUNG CANCER USING CT-SCAN IMAGES BASED ON CELLULAR LEARNING AUTOMATE
EARLY STAGE DIAGNOSIS OF LUNG CANCER USING CT-SCAN IMAGES BASED ON CELLULAR LEARNING AUTOMATE SAKTHI NEELA.P.K Department of M.E (Medical electronics) Sengunthar College of engineering Namakkal, Tamilnadu,
More informationDeveloping quantitative slide-based assays to assess target inhibition in oncology drug discovery and development
Developing quantitative slide-based assays to assess target inhibition in oncology drug discovery and development TIGA Workshop June 25-26, 2010 Doug Bowman Millennium Pharmaceuticals 2010 Millennium Pharmaceuticals
More informationCANCER. Clinical Validation of Breast Cancer Predictive Markers
Clinical Validation of Breast Cancer Predictive Markers David Hicks, MD Loralee McMahon, MS, HTL(ASCP) CANCER The human body is composed of billions of highly regulated cells Cancer cells no longer respond
More informationCleveland Clinic Laboratories Hematology Diagnostic Services. Trust in us for everything you need in a reference lab.
Cleveland Clinic Laboratories Hematology Diagnostic Services Trust in us for everything you need in a reference lab. Our Mission The Pathology and Laboratory Medicine Institute contributes to excellent
More informationCC01 - Colon Cancer Tissue Microarray
Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA CC01 - Colon Cancer Tissue Microarray
More informationBioimaging and Functional Genomics
Bioimaging and Functional Genomics Elisa Ficarra, EPF Lausanne Giovanni De Micheli, EPF Lausanne Sungroh Yoon, Stanford University Luca Benini, University of Bologna Enrico Macii,, Politecnico di Torino
More informationUntangling the tumor microenvironment
Webinar Series Untangling the tumor microenvironment Illuminating the complex interactions & functions of immune cells December 10, 2014 Instructions for Viewers To share webinar via social media: To share
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schuster SJ, Svoboda J, Chong EA, et al. Chimeric antigen receptor
More informationProceedings of the UGC Sponsored National Conference on Advanced Networking and Applications, 27 th March 2015
Brain Tumor Detection and Identification Using K-Means Clustering Technique Malathi R Department of Computer Science, SAAS College, Ramanathapuram, Email: malapraba@gmail.com Dr. Nadirabanu Kamal A R Department
More informationAUTOMATIC DIABETIC RETINOPATHY DETECTION USING GABOR FILTER WITH LOCAL ENTROPY THRESHOLDING
AUTOMATIC DIABETIC RETINOPATHY DETECTION USING GABOR FILTER WITH LOCAL ENTROPY THRESHOLDING MAHABOOB.SHAIK, Research scholar, Dept of ECE, JJT University, Jhunjhunu, Rajasthan, India Abstract: The major
More informationCarnegie Mellon University Annual Progress Report: 2011 Nonformula Grant
Carnegie Mellon University Annual Progress Report: 2011 Nonformula Grant Reporting Period July 1, 2012 June 30, 2013 Nonformula Grant Overview Carnegie Mellon University received $983,783 in nonformula
More informationCINtec PLUS Cytology. Interpretation training
CINtec PLUS Cytology Interpretation training Objectives After reviewing this learning module, you will have a basic understanding of how to interpret CINtec PLUS Cytology, including: The mechanism of action
More informationANALYTISCHE STRATEGIE Tissue Imaging. Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich
ANALYTISCHE STRATEGIE Tissue Imaging Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich Quantitative Breast single cancer cell analysis Switzerland Brain Breast Lung Colon-rectum
More informationA comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome
1 Department of General Surgery, Manchester Royal Infirmary, Oxford Road, Manchester, UK 2 Medical Genetics Research Group and Regional Genetics Service, University of Manchester and Central Manchester
More informationQuantitation of microrna 92a in colorectal adenocarcinoma and its precancerous lesions: Co utilization of in situ hybridization and spectral imaging
ONCOLOGY LETTERS 9: 1109-1115, 2015 Quantitation of microrna 92a in colorectal adenocarcinoma and its precancerous lesions: Co utilization of in situ hybridization and spectral imaging I WENG LAO 1, FENGYUN
More informationRSNA, /radiol Appendix E1. Methods
RSNA, 2016 10.1148/radiol.2016151097 Appendix E1 Methods US and Near-infrared Data Acquisition Four optical wavelengths (740 nm, 780 nm, 808 nm, and 830 nm) were used to sequentially deliver the light
More informationAugmented Medical Decisions
Machine Learning Applied to Biomedical Challenges 2016 Rulex, Inc. Intelligible Rules for Reliable Diagnostics Rulex is a predictive analytics platform able to manage and to analyze big amounts of heterogeneous
More informationKi67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
ARTICLE Ki67 Index, HER2 Status, and Prognosis of Patients With Breast Cancer Maggie C. U. Cheang, Stephen K. Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri Davies,
More informationData integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate
Ma et al. Diagnostic Pathology (2017) 12:69 DOI 10.1186/s13000-017-0658-8 RESEARCH Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate
More informationClaudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression
Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta
More informationBreast Cancer Interpretation Guide
Breast Cancer Interpretation Guide UCT D O R P NEW ERBB2/ C E P S ht e ZytoLig lor Prob o C l a u 2D D17S12 ng to the i d r o c c a ting for re-tes idelines 2013 ASCO Gu Breast Cancer Interpretation Guide
More informationCorrelation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer B
Human Pathology (2005) 36, 1302 1308 www.elsevier.com/locate/humpath Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer
More informationPathology Report Patient Companion Guide
Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit
More informationSupplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in
Supplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in nulliparous (left panel) and InvD6 mouse mammary glands (right
More informationImmunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on
Supplemental Methods Immunohistochemical Analyses Immunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on prostatectomy sections obtained post-study. Briefly,
More information11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS
Bharat N. Nathwani, M.D. City of Hope Medical Center Professor, Director of Pathology Consultation Services, 1500 East Duarte Road, Duarte, California, 91010 DISCLOSURES -------------------------------------------------------
More informationUtilizing machine learning techniques to rapidly identify. MUC2 expression in colon cancer tissues
1 Utilizing machine learning techniques to rapidly identify MUC2 expression in colon cancer tissues Thesis by Preethi Periyakoil In partial fulfillment of the requirements for the degree of Bachelor of
More informationGuideline. Associated Documents ASCO CAP 2018 GUIDELINES and SUPPLEMENTS -
Guideline Subject: ASCO CAP 2018 HER2 Testing for Breast Cancer Guidelines - Recommendations for Practice in Australasia Approval Date: December 2018 Review Date: December 2022 Review By: HER2 testing
More informationAssessment Run B HER2 IHC
Assessment Run B26 208 HER2 IHC Material The slide to be stained for HER2 comprised the following 5 materials: IHC: HER2 Score* (0, +, 2+, 3+) FISH: HER2 gene/chr 7 ratio**. Breast carcinoma, no. 2+..3
More informationAbbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation
Laboratory Hematology 8:85-90 2002 Carden Jennings Publishing Co.. Ltd. Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation T. SCHISANO, L. VAN HOVE Abbott
More informationEstrogen receptor (ER)
Assessment Run B7 204 Estrogen receptor (ER) Material The slide to be stained for ER comprised: No. Tissue ER-positivity* ER-intensity*. Uterine cervix 80-90% Moderate to strong 2. Breast carcinoma 0%
More informationSupplementary Information
Supplementary Information Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin embedded colon cancer tissue Camilla Natasha Cederbye 1, Jesper Andreas
More informationTissue microarray TMA
Tissue microarray TMA Tibor Krenacs 1st Department of Pathology & Experimental Cancer Research Semmelweis University Budapest Austro-Hungarian Pathology Congress October 1-3rd 2009 TMA - tissue microarray
More informationNoninvasive Blood Glucose Analysis using Near Infrared Absorption Spectroscopy. Abstract
Progress Report No. 2-3, March 31, 1999 The Home Automation and Healthcare Consortium Noninvasive Blood Glucose Analysis using Near Infrared Absorption Spectroscopy Prof. Kamal Youcef-Toumi Principal Investigator
More informationIBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina
Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia
More informationFluorescence Microscopy
Fluorescence Microscopy Imaging Organelles Mitochondria Lysosomes Nuclei Endoplasmic Reticulum Plasma Membrane F-Actin AAT Bioquest Introduction: Organelle-Selective Stains Organelles are tiny, specialized
More informationResearch Article. Automated grading of diabetic retinopathy stages in fundus images using SVM classifer
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(1):537-541 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Automated grading of diabetic retinopathy stages
More informationBreast Cancer Diversity Various Disease Subtypes Clinical Diversity
Breast Cancer Predictive Factor Testing: The Challenge and Importance of Standardizing Pre- Analytic Variables David G. Hicks MD Professor of Pathology & Laboratory Medicine Director of Surgical Pathology
More information